We are live on ! Find out more
PM

Ponoi Management Portfolio holdings

AUM $73.2M
1-Year Est. Return 23.44%
This Fund
S&P 500
This Quarter Est. Return
+18.14%
1 Year Est. Return
-23.44%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$180M
AUM Growth
+$9.96M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNST
1
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$63.6M 35.32%
1,880,623
RAPT
2
DELISTED
RAPT Therapeutics
RAPT
$50.8M 28.25%
199,927
NGM
3
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$25.6M 14.23%
1,298,908
RVMD icon
4
Revolution Medicines
RVMD
$47.4B
$21.7M 12.08%
685,011
NRIX icon
5
Nurix Therapeutics
NRIX
$2.79B
$18.2M 10.12%
686,274

Similar funds

Ponoi Management's Q2 2021 Portfolio in Review

As of Q2 2021, Ponoi Management held 5 positions worth $180M, up 5.9% from $170M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2021: portfolio turnover was 0%. Ponoi Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Ponoi Management's ten largest holdings make up 100% of its $180M portfolio in Q2 2021.
  • Ponoi Management opened 0 new positions and closed 0 in Q2 2021.
  • Ponoi Management's portfolio value rose 5.9% quarter-over-quarter to $180M.

Based on Ponoi Management's 13F filing for Q2 2021, filed 16 Aug 2021.